In this study, ⭕AS pts w/>=2 #comorbidities were associated w/ poorer outcome measures after 2 yrs of ffup vs. pts w/ no comorbids ⭕Pts w/ >=2 comorbids were likely to dc 1st anti-TNF Address comorbidities, ⬆ chances of better outcomes & QoL @RheumNow #ACR21 abs1309 https://t.co/sTnjaC1a1l